Changes in pricing of medical products
Belarus: Decree no 228 of 21 June 2016 establishes new rules for pricing of pharmaceuticals, medical devices and medical equipment (“medical…
Read more
Sales of mid- and high-priced drugs in Russia continue to decline
Sales of mid- and high-priced drugs in Russia are steadily declining, due to the ongoing economic stagnation in the country…
Czech Pharma Industry Leaders Meet to Discuss New Legislation
Prague, 20 June 1016 – The Prague office of Baker & McKenzie recently hosted the latest in a series of…
Medical device regulation in the EU and US needs urgent reform, say experts
Patients and clinicians need greater regulatory transparency to make informed decisions about treatment. Medical devices approved first in the European…
PSUR Repository
The PSUR repository is a single, central platform for PSURs and related documents to be used by all regulatory authorities…
BNT Baltic Pharma Law Survey 2015
The BNT Baltic Pharma Law Survey 2015 provides actionable insights into the pharmaceutical regulatory and competition law, pricing, reimbursement and…
EU Council and Parliamentary Committees Sign Off on New Medical Device, IVD Regulations
The European Council’s Permanent Representatives Committee and the European Parliament’s Environment and Health Committee on Wednesday endorsed the agreement reached…
Generic drug market in Central Europe to develop by 3%-6% pa between 2016 and 2021
According to estimates from Poland-based market research group PMR, Poland will be the most rapidly developing… In order to access…
EFPIA to extend collaboration with Lithuania on pharmaceutical policy
On 22nd April 2016, in Vilnius, Lithuania, EFPIA Director General Richard Bergström and Lithuanian Minister of Health Juras Pozela discussed…
Kazakhstan: Common Pharmaceutical Market Of The Eurasian Economic Union
Since the breakup of the Soviet Union, the former Soviet republics have been on a quest for independent development. At…